BCI Marketplace
Depression Neuromodulation trials

Home-Based tDCS for Depression in BPD

RecruitingNCT06972368Phase: NAStarted 2026-01-01

Summary

The present study aims to assess the feasibility of home-based tDCS in remote and urban areas (primary objective). The secondary aim is to obtain a preliminary assessment of the efficacy of 14 home-based tDCS sessions in reducing depressive symptoms in BPD patients with moderate to severe depressive episodes and BPD symptoms. Exploratory objectives include assessing the impact on neuropsychological and psychosocial functioning, anxiety, physical activity, sleep disorders, and addiction. Addit

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Inclusion Criteria: 1. To be aged between 18 and 65. 2. To meet the DSM-IV criteria for BPD. 3. To present a moderate depressive episode, defined as a MADRS score ≥ 20 (V1 and V3). 4. To be capable to consent to participate in the study. 5. To speak either French or English. 6. Participants must ha

Locations

IUSMM
Montreal, Quebec, Canada

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →